Abstract
Introduction: blockage caused by an isolated and moving clot in the vessels (embolism) is called pulmonary thromboembolism (PTE). Currently, pulmonary artery angiography is known as the gold standard for the diagnosis of pulmonary thromboembolism; however, in addition to its high cost, this diagnostic method has a high exposure to harmful radiation and cannot be performed in many cases. Therefore, the present study was conducted with the aim of determining the relationship between the number of blood platelets and the ratio of platelets to lymphocytes and monocytes with the prevalence and severity of pulmonary thromboembolism, to use these factors as diagnostic and prognostic tools in the initial assessment of pulmonary thromboembolism patients.
Materials and Methods: This is a case-control study. In this study, 80 patients with pulmonary thromboembolism (case group) and 80 healthy individuals referred to Imam Khomeini Hospital in Ardabil (control group) were evaluated. Data analysis was performed using SPSS version 27.
Results: The mean age of pulmonary thromboembolism patients was 40.3 years, and 56.3% were women, with no significant difference in age and gender parameters compared to the control group (P=0.068 and P=0.874, respectively). All three parameters of blood platelet count, platelet to lymphocyte ratio (PLR), and platelet to monocyte ratio (PMR) were significantly lower in the group of pulmonary thromboembolism patients compared to the control group (P-values of 0.027, 0.001, and 0.001, respectively). Furthermore, all three parameters were significantly lower in patients with massive thromboembolism compared to those with non-massive thromboembolism (P-values of 0.042, <0.001, and <0.001, respectively).
Conclusion: Inflammatory parameters such as the platelet to lymphocyte ratio and blood platelet count, as factors related to coagulation levels, are associated with the occurrence and severity of thromboembolism and can serve as helpful factors in the initial diagnosis and prognosis of pulmonary thromboembolism patients.
References 38
-
1. Ucar EY. Update on Thrombolytic Therapy in Acute Pulmonary Thromboembolism. Eurasian J Med. 2019;51(2):186-90.
-
2. Tarbox AK, Swaroop M. Pulmonary embolism. Int J Crit Illn Inj Sci. 2013;3(1):69-72.
-
3. Konstantinides S. Acute pulmonary embolism. New England Journal of Medicine. 2008;359(26):2804-13.
-
4. Ghaffari S, Parvizian N, Pourafkari L, Separham A, Hajizadeh R, Nader ND, et al. Prognostic value of platelet indices in patients with acute pulmonary thromboembolism. J Cardiovasc Thorac Res. 2020;12(1):56-62.
-
5. Kirresh A, Candilio L, Stone GW. Intralesional delivery of glycoprotein IIb/IIIa inhibitors in acute myocardial infarction: review and recommendations. Catheterization and Cardiovascular Interventions. 2022;99(3):641-9.
-
6. Sadeghi F, Kovács S, Zsóri KS, Csiki Z, Bereczky Z, Shemirani AH. Platelet count and mean volume in acute stroke: a systematic review and meta-analysis. Platelets. 2020;31(6):731-9.
-
7. Song JE, Lee DW, Han J, Kim HG. The increment of platelet count is risk factor of pulmonary thromboembolism in patients with pancreatic cancer treated with gemcitabine. Pancreatology. 2016;1(16):S54.
-
8. Swystun LL, Liaw PC. The role of leukocytes in thrombosis. Blood, The Journal of the American Society of Hematology. 2016;128(6):753-62.
-
9. Perrier A, Roy P-M, Aujesky D, Chagnon I, Howarth N, Gourdier A-L, et al. Diagnosing pulmonary embolism in outpatients with clinical assessment, D-dimer measurement, venous ultrasound, and helical computed tomography: a multicenter management study. The American journal of medicine. 2004;116(5):291-9.
-
10. Alidaei N, Zarrin S, Eishi A, Rahimi M-H. Evaluation of the relationship between platelet count, mean platelet volume and pulmonary thromboembolism. Razi J Med Sci. 2012;19(94):20-6.
-
11. Ogeng’o JA, Obimbo MM, Olabu BO, Gatonga PM, Ong’era D. Pulmonary thromboembolism in an East African tertiary referral hospital. J Thrombos Thrombol. 2011;32(3):386-91.
-
12. Nagamalesh UM, Prakash VS, Naidu KCK, Sarthak S, Hegde AV, Abhinay T. Acute pulmonary thromboembolism: Epidemiology, predictors, and long-term outcome – A single center experience. Ind Heart J. 2017;69(2):160-4.
-
13. Ghasemian Moghaddam MR, Azdaki N, Ghasemi MS. Acute Pulmonary Embolism and 1-Year Outcome: An Epidemiological Study in East of Iran, 2011-2016. Mod Care J. 2020;17(1):12-20.
-
14. Montagnana M, Favaloro EJ, Franchini M, Guidi GC, Lippi G. The role of ethnicity, age and gender in venous thromboembolism. J Thrombos Thrombol. 2010;29(4):489-96.
-
15. Bai Y, Yue QM, Sun H, Guo SD, Wang ZZ, Zhong P, et al. Prevalence and sex- and age-related risk of pulmonary embolism in in-hospital patients with atrial fibrillation: a multicenter retrospective study from China. Ann Transl Med. 2020;8(23):15-58.
-
16. Bailey AL, Scantlebury DC, Smyth SS. Thrombosis and antithrombotic therapy in women. Arterioscler Thrombos Vasc Biol. 2009;29(3):284-8.
-
17. Anderson FA, Wheeler HB, Goldberg RJ, Hosmer DW, Patwardhan NA, Jovanovic B, et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism: the Worcester DVT Study. Arch Intern Med. 1991;151(5):933-8.
-
18. Nordström M, Lindblad B, Bergqvist D, Kjellström T. A prospective study of the incidence of deep‐vein thrombosis within a defined urban population. J Intern Med. 1992;232(2):155-60.
-
19. Proctor MC, Wainess RM, Henke PK, Upchurch GR, Wakefield TW. Venous thromboembolism: regional differences in the nationwide inpatient sample, 1993 to 2000. Vascular. 2004;12(6):374-80.
-
20. Oger E, group E-Gs. Incidence of venous thromboembolism: a community-based study in Western France. Thrombos Haemostas. 2000;83(05):657-60.
-
21. Silverstein MD, Heit JA, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med. 1998;158(6):585-93.
-
22. Romero A, Alonso C, Rincón M, Medrano J, Santos J-M, Calderón E, et al. Risk of venous thromboembolic disease in women: A qualitative systematic review. Eur J Obstetr Gynecol Reproduct Biol. 2005;121(1):8-17.
-
23. Monreal M, Lafoz E, Casals A, Ruíz J, Arias A. Platelet Count and Venous Thromboembolism: A Useful Test for Suspected Pulmonary Embolism. Chest. 1991;100(6):1493-6.
-
24. Varol E, Icli A, Uysal BA, Ozaydin M. Platelet indices in patients with acute pulmonary embolism. Scand J Clin Lab Invest. 2011;71(2):163-7.
-
25. Monreal M, Lafoz E, Ruiz J, Gimenez G. Platelet count in acute pulmonary embolism: its relationship to recurrences. Haemostasis. 1993;23(5):263-8.
-
26. Huang J, Chen Y, Cai Z, Chen P. Diagnostic value of platelet indexes for pulmonary embolism. Am J Emerg Med. 2015;33(6):760-3.
-
27. Rabiepour M, Valipour H, Islampour P, pashaei MR. PREDICTIVE VALUE OF PLATELET MARKERS IN THE PATIENTS WITH ACUTE PULMONARY THROMBOEMBOLISM. Stud Med Sci. 2022;33(1):62-9.
-
28. Marongiu F, Mameli A, Grandone E, Barcellona D. Pulmonary thrombosis: a clinical pathological entity distinct from pulmonary embolism? Semin Thrombos Hemostas. 2019;45(08):778-83.
-
29. Acanfora D, Gheorghiade M, Trojano L, Furgi G, Pasini E, Picone C, et al. Relative lymphocyte count: a prognostic indicator of mortality in elderly patients with congestive heart failure. Am Heart J 2001;142(1):167-73.
-
30. Ly HQ, Kirtane AJ, Murphy SA, Buros J, Cannon CP, Braunwald E, et al. Association of platelet counts on presentation and clinical outcomes in ST-elevation myocardial infarction (from the TIMI Trials). Am J Cardiol. 2006;98(1):1-5.
-
31. Bonow RO, Fonarow GC, O’Gara PT, Yancy CW. Association of coronavirus disease 2019 (COVID-19) with myocardial injury and mortality. JAMA Cardiol. 2020;5(7):751-3.
-
32. Karataş MB, İpek G, Onuk T, Güngör B, Durmuş G, Çanga Y, et al. Assessment of prognostic value of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in patients with pulmonary embolism. Acta Cardiol Sin. 2016;32(3):313-20.
-
33. Telo S, Kuluöztürk M, Deveci F, Kirkil G. The relationship between platelet-to-lymphocyte ratio and pulmonary embolism severity in acute pulmonary embolism. J Int Union Angiol. 2019;38(1):4-9.
-
34. Ates H, Ates I, Kundi H, Yilmaz FM. Diagnostic validity of hematologic parameters in evaluation of massive pulmonary embolism. J Clin Lab. 2017;31(5):12-20.
-
35. Galliazzo S, Nigro O, Bertù L, Guasti L, Grandi AM, Ageno W, et al. Prognostic role of neutrophils to lymphocytes ratio in patients with acute pulmonary embolism: a systematic review and meta-analysis of the literature. Intern Emerg Med. 2018;13(4):603-
-
36. Zhou J, Li X, Wang M, Gu C, Liu J. Platelet-to-Monocyte Ratio as a Novel Promising Agent for the Prognosis of Hepatitis B Virus-Associated Decompensated Cirrhosis. Can J Gastroenterol Hepatol. 2023;2023:12-20.
-
37. Çaltekin İ, Demirtaş E. Is platelet to monocyte ratio a useful inflammatory determinant of ST-elevation myocardial infarction? Disaster Emerg Med J. 2020;5(4):205-11.
-
38. Białas AJ, Kornicki K, Ciebiada M, Antczak A, Sitarek P, Miłkowska-Dymanowska J, et al. Monocyte to large platelet ratio as a diagnostic tool for pulmonary embolism in patients with acute exacerbation of chronic obstructive pulmonary disease. Pol Arch Intern Med. 2018;128(1):15-23.

This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2026 Mahsa Alimoradi, Atabak Sedigh-Namin, Ghasem Aboutalebidariasari, Shafagh Aliasgarzadeh, Nazli javaheri, Sadaf Motevali (Author)